1. Home
  2. PSTX vs MBAV Comparison

PSTX vs MBAV Comparison

Compare PSTX & MBAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTX
  • MBAV
  • Stock Information
  • Founded
  • PSTX 2014
  • MBAV 2024
  • Country
  • PSTX United States
  • MBAV United States
  • Employees
  • PSTX N/A
  • MBAV N/A
  • Industry
  • PSTX Biotechnology: Biological Products (No Diagnostic Substances)
  • MBAV
  • Sector
  • PSTX Health Care
  • MBAV
  • Exchange
  • PSTX Nasdaq
  • MBAV NYSE
  • Market Cap
  • PSTX 360.4M
  • MBAV 360.4M
  • IPO Year
  • PSTX 2020
  • MBAV 2024
  • Fundamental
  • Price
  • PSTX $2.73
  • MBAV $10.03
  • Analyst Decision
  • PSTX Strong Buy
  • MBAV
  • Analyst Count
  • PSTX 2
  • MBAV 0
  • Target Price
  • PSTX $15.00
  • MBAV N/A
  • AVG Volume (30 Days)
  • PSTX 557.9K
  • MBAV 21.1K
  • Earning Date
  • PSTX 11-07-2024
  • MBAV 01-01-0001
  • Dividend Yield
  • PSTX N/A
  • MBAV N/A
  • EPS Growth
  • PSTX N/A
  • MBAV N/A
  • EPS
  • PSTX N/A
  • MBAV N/A
  • Revenue
  • PSTX $150,858,000.00
  • MBAV N/A
  • Revenue This Year
  • PSTX $64.38
  • MBAV N/A
  • Revenue Next Year
  • PSTX N/A
  • MBAV N/A
  • P/E Ratio
  • PSTX N/A
  • MBAV N/A
  • Revenue Growth
  • PSTX 203.18
  • MBAV N/A
  • 52 Week Low
  • PSTX $1.87
  • MBAV $9.97
  • 52 Week High
  • PSTX $4.27
  • MBAV $10.15
  • Technical
  • Relative Strength Index (RSI)
  • PSTX 47.45
  • MBAV N/A
  • Support Level
  • PSTX $2.63
  • MBAV N/A
  • Resistance Level
  • PSTX $2.82
  • MBAV N/A
  • Average True Range (ATR)
  • PSTX 0.33
  • MBAV 0.00
  • MACD
  • PSTX -0.04
  • MBAV 0.00
  • Stochastic Oscillator
  • PSTX 18.38
  • MBAV 0.00

About PSTX Poseida Therapeutics Inc.

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

About MBAV M3-BRIGADE ACQUISITION V CORP

M3-Brigade Acquisition V Corp is a blank check company.

Share on Social Networks: